Robert A. Winn Diversity in Clinical Trials Award Program
The Winn CDA application is a 2-step process:
(1) Letter of Intent (LOI)
(2) Full Application (by invitation only)
The LOI for the 2023-2025 Cohort will open on October 1, 2022, and close on March 14, 2023.
LOIs will be reviewed on a rolling basis. Early submissions will receive earlier notification regarding an invitation to submit a full application. Early Access Deadline - January 31, 2023: Applicants who submit LOIs by January 31, 2023, may gain early access to the full application, if invited.
The full application runs January 31 through May 12, 2023.
Candidate Profile
Eligible candidates will reflect the National Science Foundation (NSF) definition of underrepresented populations in the US Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise:
OR have a demonstrated commitment to increasing diverse patient participation in clinical trials.
Citizenship or immigration status
Eligible candidates will be US Citizens or Lawful Permanent Residents (LPRs) as defined by the US Department of Homeland Security. [NOTE: H-1B and O-1 Visa holders are eligible; the Visa must be valid during the full 2-yr period]
Professional degree
Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD
Career Phase
Eligible candidates will be Early-Stage Investigators (ESIs), defined by NIH as new investigators who have completed their terminal research degrees or medical residencies - whichever date is later - within the past 10 years and have not yet competed successfully for substantial NIH research grants. (Applicants with an RO1 or RO1 equivalent are ineligible.)
Letter of Intent (LOI) Opens:
Oct 1, 2022
LOI Closes:
Jan 31, 2023 (Early Access Deadline)
Mar 14, 2023 (Final Deadline)
Application Opens (By Invitation Only):
Jan 31, 2023
Application Closes:
May 12, 2023
Selection Process:
May 15 - Aug 1, 2023
Award Notifications:
Aug 2, 2023
Cohort 3 Begins:
Oct 2023
Note: Dates are subject to change.
What are the LOI components? Click below for more information.
Interested in what the full application entails? Click below for a peek.
Visit our Informational Webinar page to view a recorded webinar!
Email the Winn CDA Team with any questions!
Copyright © 2022
Robert A. Winn Diversity in Clinical Trials Award Program. All Rights Reserved.